New insights on glucose pathophysiology in gestational diabetes and insulin resistance

Current Diabetes Reports

Volumn 10, Issue 3, 2010, Pages 242-247

  Harlev, Avi ^a   Wiznitzer, Arnon ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Adiposity; Gestational diabetes mellitus (GDM); Intra abdominal fat; Pathophysiology

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; RESISTIN;

ADIPOSE TISSUE; CELL INFILTRATION; DISEASE ASSOCIATION; GENETIC PREDISPOSITION; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; MACROPHAGE MIGRATION; MACROSOMIA; NONHUMAN; OBESITY; OBSTETRIC CARE; PATHOGENICITY; PATHOPHYSIOLOGY; PREGNANCY DIABETES MELLITUS; REVIEW; TRANSPORT KINETICS;

ADIPOSE TISSUE; DIABETES, GESTATIONAL; FEMALE; GLUCOSE; HUMANS; INSULIN RESISTANCE; MACROPHAGES; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 77956394198     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-010-0113-7     Document Type: Review

References (32)

1. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group [no authors listed]. Diabetes 1979, 28:1039-1057.
2. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2006, 29(Suppl 1):S43-S48.
3. Jarrett RJ: Gestational diabetes: a non-entity?BMJ 1993, 306:37-38.
4. Metzger BE, Buchanan TA, Coustan DR, et al.: Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007, 30(Suppl 2):S251-S260.
5. Gottlieb AG, Galan HL: Shoulder dystocia: an update. Obstet Gynecol Clin North Am 2007, 34:501-531, xii.
6. Henriksen T: The macrosomic fetus: a challenge in current obstetrics. Acta Obstet Gynecol Scand 2008, 87:134-145.
7. Reece EA, Leguizamon G, Wiznitzer A: Gestational diabetes: the need for a common ground. Lancet 2009, 373:1789-1797.
8. Langer O: From educated guess to accepted practice: the use of oral antidiabetic agents in pregnancy. Clin Obstet Gynecol 2007, 50:959-971. This is a review summarizing the current data regarding all oral antidiabetic agents groups for treating GDM, supporting the randomized controlled trial published in 2000 by Langer et al.
9. Wiznitzer A, Mayer A, Novack V, et al.: Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am J Obstet Gynecol 2009, 201:482.e1-482.e8.
10. Shaat N, Groop L: Genetics of gestational diabetes mellitus. Curr Med Chem 2007, 14:569-583.
11. Shaat N, Karlsson E, Lernmark A, et al.: Common variants in MODY genes increase the risk of gestational diabetes mellitus. Diabetologia 2006, 49:1545-1551.
12. Shaat N, Lernmark A, Karlsson E, et al.: Avariant in the transcription factor 7-like 2 (TCF7L2) gene is associated with an increased risk of gestational diabetes mellitus. Diabetologia 2007, 50:972-979.
13. Robitaille J, Grant AM: The genetics of gestational diabetes mellitus: evidence for relationship with type 2 diabetes mellitus. Genet Med 2008, 10:240-250.
14. Enquobahrie DA, Williams MA, Qiu C, et al.: Global placental gene expression in gestational diabetes mellitus. Am J Obstet Gynecol 2009, 200:206.e1-206.e13.
15. Friedman JE, Ishizuka T, Shao J, et al.: Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 1999, 48:1807-1814.
16. Pajvani UB, Du X, Combs TP, et al.: Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 2003, 278:9073-9085.
17. Chen J, Tan B, Karteris E, et al.: Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia 2006, 49:1292-1302.
18. Cortelazzi D, Corbetta S, Ronzoni S, et al.: Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf) 2007, 66:447-453.
19. Palik E, Baranyi E, Melczer Z, et al.: Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance. Diabetes Res Clin Pract 2007, 76:351-357.
20. Zhou Y, Zhang M, Guo W, et al.: Expression of resistin protein in normal human subcutaneous adipose tissue and pregnant women subcutaneous adipose tissue and placenta. J Huazhong Univ Sci Technolog Med Sci 2006, 26:288-291.
21. Megia A, Vendrell J, Gutierrez C, et al.: Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur J Endocrinol 2008, 158:173-178.
22. Vitoratos N, Vlahos NF, Gregoriou O, et al.: Maternal and umbilical resistin levels do not correlate with infant birth weight either in normal pregnancies and or in pregnancies complicated with gestational diabetes. J Matern Fetal Neonatal Med 2010 Jan 19 [Epub ahead of print].
23. Rudich A, Kanety H, Bashan N: Adipose stress-sensing kinases: linking obesity to malfunction. Trends Endocrinol Metab 2007, 18:291-299. This is a study reviewing the concept of stress signaling in obesity, directing future investigation of different OM tissue stress.
24. Bashan N, Dorfman K, Tarnovscki T, et al.: Mitogen-activated protein kinases, inhibitory-kappaB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity. Endocrinology 2007, 148:2955-2962.
25. Harman-Boehm I, Bluher M, Redel H, et al.: Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007, 92:2240-2247.
26. Cancello R, Tordjman J, Poitou C, et al.: Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006, 55:1554-1561.
27. Bluher M, Bashan N, Shai I, et al.: Activated Ask1-MKK4- p38MAPK/JNK stress signaling pathway in human omental fat tissue may link macrophage infiltration to whole-body insulin sensitivity. J Clin Endocrinol Metab 2009, 94:2507-2515. This is an important study establishing the association between stress signaling pathway in human OM fat to obesity and a possible connection to macrophage infiltration.
28. Harlev A, Rudich A, Bashan N, et al.: Stress-signaling in subcutaneous versus omental adipose tissue in normal and GDM pregnancies: comparison to obesity-associated adipose tissue alterations. Presented at the Society for Maternal-Fetal Medicine 29th Annual Meeting. San Diego, CA; January 26-31, 2009.
29. Weisberg SP, McCann D, Desai M, et al.: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
30. Cinti S, Mitchell G, Barbatelli G, et al.: Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005, 46:2347-2355.
31. Curat CA, Miranville A, Sengenes C, et al.: From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004, 53:1285-1292.
32. Cancello R, Tordjman J, Poitou C, et al.: Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006, 55:1554-1561.